Golimumab

How is Golimumab dosed?

The dosage of golimumab can vary depending on the specific condition being treated and the individual patient's needs. It is important to follow your doctor's orders or the instructions on the prescription label. Consult with a healthcare professional for personalized dosing information.

What is the dosage form of Golimumab?

Golimumab is available in both intravenous and subcutaneous routes. The intravenous route is administered through a vein, typically at a hospital or medical facility. The subcutaneous route is administered under the skin, usually through a prefilled syringe or autoinjector. Always follow your healthcare provider's instructions regarding dosage and administration.

What medications are contraindication with Golimumab?

Golimumab is contraindicated with other medications for arthritis, such as abatacept, anakinra, adalimumab, certolizumab, etanercept, infliximab, rituximab, or tocilizumab. Using any of these together with golimumab may increase the risk of serious side effects. Consult with a doctor before taking any other medications, especially if you are being treated for arthritis.

How is Golimumab administered?

Golimumab is administered through injections. For the subcutaneous route, follow these steps:

  1. Choose an injection site with clean, dry skin on the stomach, thigh, or upper arm.
  2. Clean the injection site with an alcohol swab.
  3. Pinch and hold the skin at the injection site.
  4. Insert the needle at a 45-degree angle and inject the medicine.
  5. Use your thumb to push the plunger and inject the full dose.
  6. Withdraw the needle from the skin and apply pressure on the injection site with a cotton ball for 10 seconds to minimize bleeding. Do not rub the site. Follow your doctor's instructions and dosage recommendations when administering golimumab.

What are common precautions when taking Golimumab?

Common precautions when taking golimumab include:

  1. Avoiding contact sports or situations where bruising or injury could occur.
  2. Being cautious when using sharp objects to prevent cuts or injuries.
  3. Not having live vaccines while being treated with golimumab. Consult your doctor before having any vaccines.
  4. Not taking other medicines for arthritis without consulting your doctor.
  5. Undergoing a skin test for tuberculosis before starting treatment with golimumab. Inform your doctor if you or someone in your home has had a positive reaction to a tuberculosis skin test.
  6. Temporarily lowering the number of white blood cells and platelets, which may increase the risk of infections or bleeding. Precautions include avoiding contact with individuals with infections, consulting your doctor if you suspect an infection or experience unusual bleeding or bruising, and monitoring for signs of infection or bleeding. Please note that these precautions are general guidelines and may not cover all possible precautions or interactions. Always consult with your healthcare professional for personalized advice on the use of golimumab.